<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Acta Biochim Biophys Sin (Shanghai)</journal-id>
<journal-id journal-id-type="iso-abbrev">Acta Biochim. Biophys. Sin. (Shanghai)</journal-id>
<journal-id journal-id-type="publisher-id">abbs</journal-id>
<journal-id journal-id-type="hwp">abbs</journal-id>
<journal-title-group>
<journal-title>Acta Biochimica et Biophysica Sinica</journal-title>
</journal-title-group>
<issn pub-type="ppub">1672-9145</issn>
<issn pub-type="epub">1745-7270</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26837414</article-id>
<article-id pub-id-type="pmc">4885128</article-id>
<article-id pub-id-type="doi">10.1093/abbs/gmv135</article-id>
<article-id pub-id-type="publisher-id">gmv135</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<series-title>Editor's choice</series-title>
</article-categories>
<title-group>
<article-title>The involvement of <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ju</surname>
<given-names>Peijun</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Donghong</given-names>
</name>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff><addr-line>Shanghai Key Laboratory of Psychotic Disorders</addr-line>, <institution>Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai 201108</addr-line>, <country>China</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence address. Tel/Fax: +<fax>86-21-64901737-2572</fax>; E-mail: <email>manyucc@126.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>2</month>
<year>2016</year>
</pub-date>
<volume>48</volume>
<issue>3</issue>
<fpage>209</fpage>
<lpage>219</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>5</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author 2016. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="gmv135.pdf"></self-uri>
<abstract>
<p>Schizophrenia is a severe mental illness that afflicts nearly 1% of the world population. Although the exact pathophysiology of schizophrenia is unknown, the <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor (NMDAR), a major glutamate receptor subtype, has received great attention. The NR1 subunit is often considered indispensable for functional NMDAR assemblies, abnormal modulation of which is found in patients with schizophrenia. In this review, we discuss how disrupted function of NR1 subunits in NMDAR leads to the progression and development of symptoms of schizophrenia-like behaviors in a variety of genetically modified mouse models. We also discuss some of the susceptible genes and shared signaling pathways among the schizophrenia, and how their mutations lead to NR1 subunits hypofunction. Finally, we suggest that the subunit-selective modulators of NR1 subunits in NMDA receptors may be promising tools for the therapy of schizophrenia.</p>
</abstract>
<kwd-group>
<kwd>NR1 subunit</kwd>
<kwd>NMDA receptor</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>Natural Science Foundation of Shanghai, China</funding-source>
<award-id>14ZR1435900</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>Qihang Personnel Training Program of Shanghai Mental Health Center</funding-source>
<award-id>2013-QH-01</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>National Natural Science Foundation of China <named-content content-type="funder-id">http://dx.doi.org/10.13039/501100001809</named-content></funding-source>
<award-id>81271481</award-id>
<award-id>81171266</award-id>
<award-id>81501153</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>